期刊
MEDICAL ONCOLOGY
卷 30, 期 1, 页码 -出版社
HUMANA PRESS INC
DOI: 10.1007/s12032-012-0338-1
关键词
Glioblastoma; Brain tumor; Tumor treatment fields; Recurrent tumor; Survival
类别
资金
- Novocure clinical trial sponsorship
We present a 48-year-old male with recurrent glioblastoma (GBM) who was enrolled in the NovoTTF-100A landmark phase III study and has been on device for [6 years. During this time, his magnetic resonance images demonstrated initial growth followed by a slow decrease in enhancement with continued residual disease. Long-term survivors in patients with recurrent GBM are rare, especially in the absence of definitive local treatment such as surgery or radiosurgery. We present the clinical, imaging and pathological findings for this patient in relation to use of the NovoTTF-100A device.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据